Comment
These results support the observation of many clinicians that aggressive treatment of systolic hypertension in frail older patients with multiple comorbidities might not be necessary and could be harmful. This study also adds to the growing literature on the importance of assessing frailty as an important component of clinical decision making.
Journal Watch © 2012 Massachusetts Medical Society